glp-1 drugs for obesity World Health Organization issues first-ever guidelines use of weight loss medications World Health Organization recommends GLP-1

Begin or continue resistance training at least three times per week

Healthcare Systems and Providers: As referenced above, health systems will need to understand how a reduction in certain diseases and a healthier population will impact the demand for different services, and how they need to adapt their service configuration to meet evolving population needs

Additionally, the FDA recommends that these medications not be taken during pregnancy and be discontinued at least two months prior to pregnancy, because studies in rats, rabbits, and monkeys demonstrated that animals treated with these medications had higher rates of miscarriage, were born smaller, and were more likely to have birth defects

But the real-world cause and effect is the same

Relationship of Glicentin to Proglucagon and Glucagon in the Porcine Pancreas